Contura Vet USA

Contura Vet is a veterinary medical technology company specializing in the development and commercialization of polyacrylamide hydrogels for the treatment of joint issues in animals. The company's flagship product, Arthramid Vet, is a biocompatible, non-resorbable hydrogel used to treat osteoarthritis and joint lameness in horses and dogs. Unlike traditional therapies, the hydrogel integrates into the synovial membrane to provide long-lasting structural support and pain relief. Contura Vet operates as a division of the Danish company Contura International, leveraging over 20 years of experience in human soft tissue augmentation. The company focuses on providing minimally invasive, long-term solutions for sports medicine and rehabilitation in the veterinary field.